Tariff item · Chapter 30 · Section VI, Products of the chemical or allied industries
HS 3002 12 30Antisera and other blood fractions: for rabies
Pharmaceutical products › Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and other similar products; cell cultures, whether or not modified
- Customs duty
- 10%
- Tariff rate
- GST now
- 0%, 5% or 18%
- depending on the goods
- Import policy
- Free
- Export policy
- Free
- Unit
- kg
- Duty in China
- 0%
- On Indian goods
Importing into India
What customs charges, what trade agreements take off, and the rules the goods must meet.
Customs duty
| Duty | Rate | Charged on |
|---|---|---|
| Basic customs duty (BCD), MFN rate | 10% | Assessable value |
| Agriculture Infrastructure and Development Cess (AIDC) | Nil | Assessable value11/2021-Customs, S.No. 17 |
| Social Welfare Surcharge (SWS) | 10% of BCD, AIDC and Health Cess | BCD + AIDC |
| Integrated GST (IGST) | 0%, 5% or 18% | Assessable value + BCD + AIDC + SWS |
Lower duty under trade agreements
| Agreement | Customs duty | Goods from |
|---|---|---|
| ASEAN–India FTA | 0% | Brunei, Indonesia, Cambodia, Laos, Myanmar, Malaysia, Philippines, Singapore, Thailand, Vietnam |
| Duty-free tariff preference for LDCs | 0% | Afghanistan, Bangladesh, Burkina Faso, Burundi, Benin, Democratic Republic of the Congo, Central African Republic, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Cambodia, Comoros, Laos, Liberia, Lesotho, Madagascar, Mali, Myanmar, Malawi, Mozambique, Niger, Rwanda, Sudan, Sierra Leone, Senegal, Somalia, Chad, Togo, Timor-Leste, Tanzania, Uganda, Yemen, Zambia |
| India–Japan CEPA | 0% | Japan |
| India–Korea CEPA | 0% | South Korea |
| India–Malaysia CECA | 0% | Malaysia |
| India–Singapore CECA | 0% | Singapore |
| India–Sri Lanka FTA | 0% | Sri Lanka |
| India–UAE CEPA | 0% | United Arab Emirates |
| India–UK CETA29/2026-Customs | 0% | United Kingdom |
| SAFTA | 0% | Afghanistan, Bangladesh, Bhutan, Maldives, Nepal |
| SAPTA | 0% | Bangladesh, Bhutan, Maldives, Nepal |
| India–Australia ECTA | 2% | Australia |
| SAFTA | 5% | Sri Lanka |
| India–EFTA TEPA51/2025-Customs | 8% | Switzerland, Liechtenstein |
| India–EFTA TEPA53/2025-Customs | 9% | Iceland, Norway |
| India–Oman CEPA20/2026-Customs | 9.5% | Oman |
Goods from Pakistan pay 200%.
Anti-dumping, countervailing and safeguard duty
None in force on this code as on 19 Oct 2026.
Clearance by other agencies
- Central Drugs Standard Control Organization (CDRUG): a clearance or certificate before the goods arrive, under The Drugs and Cosmetics Act, 1945 amended vide The Drugs and Cosmetics(Amendment) Act ,2008 and Rules, 1945.
Documents: Registration Certificate (Drugs) (CDRUG); Registration Certificate (Cosmetics) (CDRUG); License to import Drugs (Excluding those specified in Schedule-X) (CDRUG).
"*In case of PGA facilitated bills I.E. which have not been routed through PGA for NOC,proper officer should verify and ensure that the mandatory documents-registration certificate (drugs)[101dc1], import license for drugs[9111dc]have been uploaded in (E-SANCHIT) before giving out-of-charge(OOC)*"
From Central Board of Indirect Taxes and Customs (CBIC), Compliance Information Portal.
Import policy (DGFT ITC(HS))
- Free.
Notes on these rates
- BCD is the statutory tariff rate from a one-time snapshot of the Indian Trade Portal. Exemption notifications (such as 45/2025-Customs) and tariff changes made after the snapshot, including the Finance Act 2026 changes from 1 May 2026, are not applied.
- IGST comes from our archived GST table, which still has the 12% and 28% slabs, so it may pre-date the GST rate changes of 22 September 2025. Check the current rate.
- AIDC, Health Cess and the SWS exemptions are read from notifications 11/2021-Customs, 08/2020-Customs and 11/2018-Customs as amended (to 16/2026-Customs), and the notifications that lower AIDC for a while. SWS is 10% of BCD, AIDC and Health Cess together (Finance Act 2018, s.110), never of anti-dumping, countervailing or safeguard duty or IGST.
- AIDC is Nil (S.No. 17 of 11/2021-Customs, which exempts all goods it does not name).
- Not included: GST compensation cess, anti-dumping, countervailing and safeguard duties, and exemptions or concessions such as end-use, EOU/SEZ or project imports.
- This does not check whether the import is allowed (DGFT import policy, licences, quality-control orders). The HS code explorer shows the import policy.
- This is an estimate, not an assessment. Confirm the duty with your customs broker or ICEGATE's duty calculator before you price a deal.
GST
IGST on imports is the GST rate. Rates changed on 22 September 2025.
- Now 0%, 5% or 18%, depending on the goods.
- Until 21 September 2025 0%, 5% or 12%, depending on the goods.
- Change: Changed.
The rules that set it now
| Notification | Goods | Rate |
|---|---|---|
| 10/2025-Integrated Tax (Rate)Schedule Exempt, S.No. 114 | Human Blood and its components | Nil |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 231 | Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures whether or not modified | 5% |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 232 | Animal or Human Blood V accines | 5% |
| 10/2025-Integrated Tax (Rate)Schedule Exempt, S.No. 113 | Drugs or medicines listed in Annexure I | Nil |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 224 | Following goods from Natural Menthol namely:- a. Menthol and menthol crystals, b. Peppermint (Mentha Oil), c. Fractionated / de-terpenated mentha oil (DTMO) d. De-mentholised oil (DMO), e. Spearmint oil f. Mentha piperita oil | 5% |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 225 | Insulin, Cyclosporin, Desferrioxamine injection or deferiprone, Oral re-hydration salts | 5% |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 226 | All Drugs and medicines including their salts and esters and diagnostic test kits; formulations manufactured from bulk drugs [other than those specified at nil at S. No. 113 of notification No. 10/2025-Integrated Tax (Rate) dated 17th September, 2025] | 5% |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 227 | Diagnostic kits for detection of all types of hepatitis | 5% |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 228 | Medicaments (including veterinary medicaments) used in bio- chemic systems | 5% |
| 9/2025-Integrated Tax (Rate)Schedule I, S.No. 229 | Medicaments (including those used in Ayurvedic, Unani, Siddha, Homeopathic or Bio-chemic systems), manufactured exclusively in accordance with the formulae described in the authoritative books specified in the First Schedule to the Drugs and Cosmetics Act, 1940 (23 of 1940) or Homeopathic Pharmacopoeia of India or the United States of America or the United Kingdom or the German Homeopathic Pharmacopoeia, as the case may be, and sold under the name as specified in such books or pharmacopoeia | 5% |
| 9/2025-Integrated Tax (Rate)Schedule II, S.No. 38 | Following goods made from other than natural menthol, namely:- a. Menthol and menthol crystals, b. Peppermint (Mentha Oil) c. Fractionated / de-terpenated mentha oil (DTMO) d. De-mentholised oil (DMO) e. Spearmint oil f. Mentha piperita oil | 18% |
History
| Period | Rate | Notification |
|---|---|---|
| Until 15 Jan 2025 | 0%, 5% or 12% | 2/2017-Central Tax (Rate); 1/2017-Central Tax (Rate) |
| 16 Jan 2025 to 21 Sep 2025 | 0%, 5% or 12% | 2/2017-Central Tax (Rate); 1/2017-Central Tax (Rate); 2/2025-Central Tax (Rate) |
| From 22 Sep 2025 | 0%, 5% or 18% | 10/2025-Integrated Tax (Rate); 9/2025-Integrated Tax (Rate) |
Exporting from India
Export duty
Nil. The Second Schedule to the Customs Tariff Act does not list these goods, so no export duty is charged.
Duty drawback (All Industry Rates)
| Drawback item | Goods | Rate | Cap |
|---|---|---|---|
| 3002 | Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro- organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified | Nil | — |
Drawback items follow the 4-digit heading, not the 8-digit code: claim the one that describes your goods. Rates of notification 77/2023-Customs (N.T.) as amended, in force on 19 Oct 2026.
Export incentives (RoDTEP and RoSCTL)
- RoDTEP, Appendix 4R (exports from the domestic tariff area): 0.5% of the FOB value, until 31 Dec 2026.
- RoDTEP, Appendix 4RE (exports under Advance Authorisation, EOU or SEZ): 0.3% of the FOB value, until 31 Dec 2026.
Clearance by other agencies
- Central Drugs Standard Control Organization (CDRUG): a clearance or certificate before export, under The Drugs and Cosmetics Act, 1945 amended vide The Drugs and Cosmetics(Amendment) Act ,2008 and Rules, 1945.
- Directorate General Of Health Services (DGHS): a clearance or certificate before export.
*AS PER S.NO 152 OF SCHED. 2 OF ITC HS EXPORT POLICY;EXPORT OF WHOLE HUMAN BLOOD PLASMA AND ALL PRODUCTS DERIVED FROM HUMAN BLOOD EXCEPT GAMMA GLOBULIN AND HUMAN SERUM ALBUMIN MANUFACTURED FROM HUMAN PLACENTA AND HUMAN PLACENTAL BLOOD; RAW PLACENTA; PLACENTAL BLOOD PLASMA IS FREE SUBJECT TO OBTAINING NOC FROM DGHS.*AS PER S.NO 156 OF SCHED. 2 OF ITC HS EXPORT POLICY;EXPORT OF HEMOGLOBIN BLOOD GLOBULINS AND SERUM GLOBULINS IS FREE HOWEVER EXPORT OF THE ITEM PRODUCED FROM ANIMAL BY-PRODUCTS ALLOWED FREELY BUT EXPORT TO EUROPEAN UNION ALLOWED SUBJECT TO SPECIFIED CONDITIONS.* AS PER APPENDIX 3 CATEGORY 1A TO ITC(HS), SCHEDULE 2 - EXPORT POLICY, EXPORT OF SAXITOXIN & RICIN IS PROHIBITED.* FOR DRUGS AND PHARMACEUTICALS CDSCO NOC IS REQD EXCEPT WHEN EXEMPTED.REF-DCGI/MISC/2015(199) ORDER DTD 21.3.18* AS PER CIR NO.47/2017-CUS DTD 27/11/2017 FOR THE PURPOSE OF GRANT OF DRAWBACK WHEREVER EXPORT CONSIGNMENTS ARE SELECTED FOR ASSESSMENT OR EXAMINATION, THE AC/DC SHALL DETERMINE THE NEED TO DRAW SAMPLE ON MERITS OF EACH CASE.IF THE PACKING IS OF WOODEN MATERIAL, ENSURE THE VALID PHYTOSANITARY CERTIFICATE AND ISPM-15 MARKING COMPLIANCE AS PER CBEC INSTR. F.NO.450/19/2005-CUS-IV DTD 16.9.13.*
From Central Board of Indirect Taxes and Customs (CBIC), Compliance Information Portal.
Export policy (DGFT ITC(HS) Schedule 2)
- Free under DGFT 72/2023 of 11 Mar 2024.
- Condition: Subject to Policy Condition 6 of the Chapter.
What buyers pay abroad: import duty in the US, UK, EU and Australia for 3002 12, and China's below.
China: the same goods (3002 12)
China shares the first 6 digits with India and splits them into 10-digit codes of its own: 5 in force and 15 expired under 3002 12. Exporters see what China charges Indian goods; importers see the rebate and licences their Chinese supplier deals with.
| China code | Goods | Duty on Indian goods | MFN | Import VAT | Export rebate | Licences |
|---|---|---|---|---|---|---|
| 3002.12.00.23 | Antisera and other blood fractions containing human genetic resources含有人类遗传资源的抗血清及其他血份 | 0%China's provisional rate, lower than MFN | 3% | 13% | 13% | ABVPQVW |
| 3002.12.00.30 | Animal sera products兽用血清制品 | 0%China's provisional rate, lower than MFN | 3% | 13% | 13% | ABRPVQW |
| 3002.12.00.93 | Orphan drug preparations罕见病药品制剂 | 0%China's provisional rate, lower than MFN | 3% | 3% | 13% | ABPVQW |
| 3002.12.00.94 | Other antisera and other blood fractions containing endangered animal ingredients其他含濒危动物成分的抗血清及血份 | 0%China's provisional rate, lower than MFN | 3% | 13% | 0% | ABEFPVQW |
| 3002.12.00.99 | Other antisera and other blood fractions其他抗血清及其他血份 | 0%China's provisional rate, lower than MFN | 3% | 13% | 13% | ABPQVW |
- India is a member of the Asia-Pacific Trade Agreement (APTA). With an APTA certificate of origin, Indian goods pay China's APTA rate where the line has one; China applies the lower of that and its provisional rate.
- The export VAT rebate is what China refunds its own exporters. When China cuts it, Chinese export prices tend to rise.
Every Chinese code in full
3002.12.00Antisera and other blood fractions
3002.12.00.23Antisera and other blood fractions containing human genetic resources含有人类遗传资源的抗血清及其他血份
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- 0%
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 23 Aug 2026
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- VHuman genetic resources export certificate人类遗传资源材料出口出境证明
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
- 7.Ingredients成分
- 8.Source来源
- 9.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 10.Model型号
- 11.Packing specifications包装规格
- 12.GTIN
- 13.CAS
- 14.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.2%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
- Maldives
- 0%
- Cambodia
- 0%
- Nicaragua
- 0%
- Ecuador
- 0%
- Serbia
- 0%
- Hong Kong
- 0%
- Macao
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- South Korea
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 1.6%
- Indonesia
- 0%
- Philippines
- 0%
- Myanmar
- 0%
CIQ codes
- 3002120023401Antisera and other blood fractions containing human genetic resources (containing Class 1 pathogenic microorganisms from the 'List of Pathogenic Microorganisms Transmissible to Humans')含人类遗传资源的抗血清及其他血份(含《人间传染的病原微生物名录》内一类病原微生物)
- 3002120023402Antisera & other blood fractions, containing human genetic resources (incl. Class II pathogenic microorganisms from the List of Pathogenic Microorganisms Infectious to Humans)含人类遗传资源的抗血清及其他血份(含《人间传染的病原微生物名录》内二类病原微生物)
- 3002120023403Antisera and other blood fractions containing human genetic resources (containing Class 3 pathogenic microorganisms from the 'List of Pathogenic Microorganisms Transmissible to Humans')含人类遗传资源的抗血清及其他血份(含《人间传染的病原微生物名录》内三类病原微生物)
- 3002120023404Antisera & other blood fractions, containing human genetic resources (incl. Class IV pathogenic microorganisms from the List of Pathogenic Microorganisms Infectious to Humans)含人类遗传资源的抗血清及其他血份(含《人间传染的病原微生物名录》内四类病原微生物)
- 3002120023405Antisera and other blood fractions containing human genetic resources (containing pathogenic microorganisms of newly emerging infectious diseases or re-emerging infectious diseases outside the 'List of Pathogenic Microorganisms Transmissible to Humans')含人类遗传资源的抗血清及其他血份(含《人间传染的病原微生物名录》内新发传染病或名录外再现传染病病原微生物)
- 3002120023406Antisera and other blood fractions containing human genetic resources (containing parasites, for human medicine, life science research, excluding those managed as drugs, veterinary drugs, medical devices)含人类遗传资源的抗血清及其他血份(含寄生虫,人类医学、生命科学研究用,纳入药品、兽药、医疗器械管理的除外)
- 3002120023407Antisera and other blood fractions containing human genetic resources (other antisera, for human medical/life science research, excluding those managed as medicaments, veterinary medicaments, or medical devices)含人类遗传资源的抗血清及其他血份(其他抗血清,人类医学、生命科学研究用,纳入药品、兽药、医疗器械管理的除外)
- 3002120023408Antisera and other blood fractions containing human genetic resources (other blood fractions for human medicine, life science research, excluding those managed as drugs, veterinary drugs, medical devices)含人类遗传资源的抗血清及其他血份(其他血份,人类医学、生命科学研究用,纳入药品、兽药、医疗器械管理的除外)
- 3002120023999Antisera & other blood fractions containing human genetic resources (under pharmaceutical management)含人类遗传资源的抗血清及其他血份(纳入药品管理的)
3002.12.00.30Animal sera products兽用血清制品
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- 0%
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 23 Aug 2026
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- RImported veterinary drugs clearance certificate进口兽药通关单
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
- 7.Ingredients成分
- 8.Source来源
- 9.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 10.Model型号
- 11.Packing specifications包装规格
- 12.GTIN
- 13.CAS
- 14.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.2%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
- Maldives
- 0%
- Cambodia
- 0%
- Nicaragua
- 0%
- Ecuador
- 0%
- Serbia
- 0%
- Hong Kong
- 0%
- Macao
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- South Korea
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 1.6%
- Indonesia
- 0%
- Philippines
- 0%
- Myanmar
- 0%
CIQ codes
- 3002120030999Animal sera products兽用血清制品
3002.12.00.93Orphan drug preparations罕见病药品制剂
incl. related goods from the first and second lists of rare disease drugs包括罕见病药品清单第一批、第二批相关商品
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 3%
- Consumption tax
- 0%
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 23 Aug 2026
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
- 7.Ingredients成分
- 8.Source来源
- 9.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 10.Model型号
- 11.Packing specifications包装规格
- 12.GTIN
- 13.CAS
- 14.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.2%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
- Maldives
- 0%
- Cambodia
- 0%
- Nicaragua
- 0%
- Ecuador
- 0%
- Serbia
- 0%
- Hong Kong
- 0%
- Macao
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- South Korea
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 1.6%
- Indonesia
- 0%
- Philippines
- 0%
- Myanmar
- 0%
CIQ codes
- 3002120093401Formulations of drugs for rare diseases (incl. related products in the 1st and 2nd lists of drugs for rare diseases) (other human blood products)罕见病药品制剂(包括罕见病药品清单第一批、第二批相关商品)(其他人血制品)
3002.12.00.94Other antisera and other blood fractions containing endangered animal ingredients其他含濒危动物成分的抗血清及血份
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- 0%
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 0%
- Updated by China
- 7 Sep 2026
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- EEndangered species export permit濒危物种允许出口证明书
- FEndangered species import permit濒危物种允许进口证明书
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
- 7.Ingredients成分
- 8.Source来源
- 9.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 10.Model型号
- 11.Packing specifications包装规格
- 12.GTIN
- 13.CAS
- 14.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.2%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
- Maldives
- 0%
- Cambodia
- 0%
- Nicaragua
- 0%
- Ecuador
- 0%
- Serbia
- 0%
- Hong Kong
- 0%
- Macao
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- South Korea
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 1.6%
- Indonesia
- 0%
- Philippines
- 0%
- Myanmar
- 0%
CIQ codes
- 3002120094101Other antisera and other blood fractions containing endangered animal ingredients (monkey plasma)其他含濒危动物成分的抗血清及血份(猴血浆)
- 3002120094102Other antisera and other blood fractions containing endangered animal ingredients (other endangered animal plasma)其他含濒危动物成分的抗血清及血份(其他濒危动物血浆)
- 3002120094103Other antisera and other blood fractions containing endangered animal ingredients (monkey serum)其他含濒危动物成分的抗血清及血份(猴血清)
- 3002120094104Other antisera and other blood fractions containing endangered animal ingredients (other endangered animal serum)其他含濒危动物成分的抗血清及血份(其他濒危动物血清)
- 3002120094105Other antisera and other blood fractions containing endangered animal components (animal blood containing Class 1, 2 or 3 animal pathogenic microorganisms listed in the 'Classification Catalogue of Animal Pathogenic Microorganisms')其他含濒危动物成分的抗血清及血份(含有《动物病原微生物分类名录》内第一、二、三类动物病原微生物的动物血液)
- 3002120094106Other antisera and blood fractions containing endangered animal components (animal blood containing Category 4 animal pathogenic microorganisms as per the 'Catalogue of Animal Pathogenic Microorganisms')其他含濒危动物成分的抗血清及血份(含有《动物病原微生物分类名录》内第四类动物病原微生物的动物血液)
- 3002120094107Other antisera and other blood fractions containing endangered animal components (effectively inactivated animal-derived samples for research)其他含濒危动物成分的抗血清及血份(经有效灭活的科研用动物源性样品)
3002.12.00.99Other antisera and other blood fractions其他抗血清及其他血份
Residual tariff heading resulting from the splitting of anti-cancer drugs因拆分抗癌药产生的兜底税号
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- 0%
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 23 Aug 2026
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
- 7.Ingredients成分
- 8.Source来源
- 9.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 10.Model型号
- 11.Packing specifications包装规格
- 12.GTIN
- 13.CAS
- 14.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.2%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
- Maldives
- 0%
- Cambodia
- 0%
- Nicaragua
- 0%
- Ecuador
- 0%
- Serbia
- 0%
- Hong Kong
- 0%
- Macao
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- South Korea
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 1.6%
- Indonesia
- 0%
- Philippines
- 0%
- Myanmar
- 0%
CIQ codes
- 3002120099101Other antisera or other blood fractions (porcine blood powder, for anti-cancer drug sub-division)其他抗血清或其他血份(猪血粉,因拆分抗癌药产生的兜底税号)
- 3002120099102Other antisera or other blood fractions (bovine blood powder, for anti-cancer drug sub-division)其他抗血清或其他血份(牛血粉,因拆分抗癌药产生的兜底税号)
- 3002120099103Other antisera or other blood fractions (ovine blood powder, for anti-cancer drug sub-division)其他抗血清或其他血份(羊血粉,因拆分抗癌药产生的兜底税号)
- 3002120099104Other antisera or other blood fractions (deer blood powder, for anti-cancer drug sub-division)其他抗血清或其他血份(鹿血粉,因拆分抗癌药产生的兜底税号)
- 3002120099105Other antisera or other blood fractions (poultry blood powder, for anti-cancer drug sub-division)其他抗血清或其他血份(禽血粉,因拆分抗癌药产生的兜底税号)
- 3002120099106Other antisera or other blood fractions (other animal blood powder)其他抗血清或其他血份(其他动物血粉,因拆分抗癌药产生的兜底税号)
- 3002120099107Other antisera or other blood fractions (other farmed even-toed ungulate blood powder, catch-all tariff code due to splitting anticancer drugs)其他抗血清或其他血份(其他饲养偶蹄动物血粉,因拆分抗癌药产生的兜底税号)
- 3002120099108Other antisera or other blood fractions (other wild even-toed ungulate blood powder, catch-all tariff code due to splitting anticancer drugs)其他抗血清或其他血份(其他野生偶蹄动物血粉,因拆分抗癌药产生的兜底税号)
- 3002120099109Other antisera and other blood fractions (pig blood plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(猪血浆)
- 3002120099110Other antisera and other blood fractions (horse blood plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(马血浆)
- 3002120099111Other antisera and other blood fractions (residual tariff line due to splitting of anti-cancer drugs) (rabbit plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(兔血浆)
- 3002120099112Other antisera and other blood fractions (dog blood plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(狗血浆)
- 3002120099113Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (other animal plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他动物血浆)
- 3002120099114Other antisera & other blood fractions (fetal bovine serum, finished)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(胎牛血清成品)
- 3002120099115Other antisera and other blood fractions (catch-all tariff no. due to splitting of anti-cancer drugs) (fetal bovine serum semi-finished)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(胎牛血清半成品)
- 3002120099116Other antisera and other blood fractions (catch-all tariff code due to splitting anticancer drugs) (bovine serum, finished)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(小(犊)牛血清成品)
- 3002120099117Other antisera and other blood fractions (residual tariff line due to splitting of anti-cancer drugs) (calf serum semi-finished product)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(小(犊)牛血清半成品)
- 3002120099118Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (bovine serum finished product)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(成牛血清成品)
- 3002120099119Other antisera and other blood fractions (catch-all tariff no. due to splitting of anti-cancer drugs) (bovine serum semi-finished)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(成牛血清半成品)
- 3002120099120Other antisera and other blood fractions (finished pig serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(猪血清成品)
- 3002120099121Other antisera and other blood fractions (finished horse serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(马血清成品)
- 3002120099122Other antisera and other blood fractions (residual tariff line due to splitting of anti-cancer drugs) (rabbit serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(兔血清)
- 3002120099123Other antisera and other blood fractions (residual tariff line from splitting anticancer drugs) (mouse serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(小鼠血清)
- 3002120099124Other antisera and other blood fractions (residual tariff line from splitting anticancer drugs) (rat serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(大鼠血清)
- 3002120099125Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (other animal serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他动物血清)
- 3002120099126Other antisera and other blood fractions (residual tariff line from splitting anticancer drugs) (animal inspection antigen)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(动检抗原)
- 3002120099128Other antisera and other blood fractions (animal inspection antiserum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(动检抗血清)
- 3002120099129Other antisera and other blood fractions (residual tariff line from splitting anticancer drugs) (animal inspection complement)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(动检补体)
- 3002120099130Other antisera and other blood fractions (animal inspection hemolysin)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(动检溶血素)
- 3002120099131Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (other animal blood fractions)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他动物血份)
- 3002120099132Other antisera and other blood fractions (pig whole blood)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(猪全血)
- 3002120099133Other antisera and other blood fractions (horse whole blood)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(马全血)
- 3002120099134Other antisera and other blood fractions (dog whole blood)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(狗全血)
- 3002120099135Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (other animal whole blood)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他动物全血)
- 3002120099136Other antisera and other blood fractions (mouse blood plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(鼠血浆)
- 3002120099137Other antisera and other blood fractions (guinea pig serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(豚鼠血清)
- 3002120099138Other antisera and other blood fractions (catch-all tariff number due to the dismantling of anti-cancer drugs) (animal blood containing Class 1, 2 or 3 animal pathogenic microorganisms listed in the "Classification Catalogue of Animal Pathogenic Microorganisms")其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(含有《动物病原微生物分类名录》内第一、二、三类动物病原微生物的动物血液)
- 3002120099139Other antisera and other blood fractions (animal blood containing Class IV animal pathogenic microorganisms as per the 'Catalogue of Animal Pathogenic Microorganisms')其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(含有《动物病原微生物分类名录》内第四类动物病原微生物的动物血液)
- 3002120099140Other antisera and other blood fractions (finished donkey serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(驴血清成品)
- 3002120099141Other antisera and other blood fractions (finished rat serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(鼠血清成品)
- 3002120099142Other antisera and other blood fractions (finished sheep serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(羊血清成品)
- 3002120099143Other antisera and other blood fractions (residual tariff item from splitting anticancer drugs) (finished sheep immunoglobulin)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(羊免疫球蛋白成品)
- 3002120099144Other antisera and other blood fractions (finished horseshoe crab serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(鲎血清成品)
- 3002120099145Other antisera and other blood fractions (hemocyanin)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(血蓝蛋白)
- 3002120099146Other antisera and other blood fractions (animal-origin samples for research, effectively inactivated)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(经有效灭活的科研用动物源性样品)
- 3002120099147Other antisera and other blood fractions (other mouse serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他鼠血清)
- 3002120099148Other antisera & other blood fractions (pig serum, semi-finished)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(猪血清半成品)
- 3002120099149Other antisera & other blood fractions (horse serum, semi-finished)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(马血清半成品)
- 3002120099150Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (SPF mouse serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(SPF鼠血清)
- 3002120099151Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (SPF canine serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(SPF犬血清)
- 3002120099152Other antisera and other blood fractions (residual tariff code due to splitting of anti-cancer drugs) (other SPF experimental animal serum)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他SPF实验动物血清)
- 3002120099153Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (SPF mouse plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(SPF鼠血浆)
- 3002120099154Other antisera and other blood fractions (residual tariff no. due to splitting of anti-cancer drugs) (SPF canine plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(SPF犬血浆)
- 3002120099155Other antisera and other blood fractions (residual tariff code due to splitting of anti-cancer drugs) (other SPF experimental animal plasma)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他SPF实验动物血浆)
- 3002120099156Other antisera and other blood fractions (residual tariff line from splitting anticancer drugs) (animal hemolysin)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(动物血酶)
- 3002120099401Other antisera & other blood fractions (other human blood products)其他抗血清及其他血份(其他人血制品)
- 3002120099402Other antisera and other blood fractions (clinically collected, containing Class I pathogenic microorganisms from the "Catalog of Pathogenic Microorganisms Transmissible to Humans" that have not been effectively inactivated)其他抗血清及其他血份(临床采集,含《人间传染的病原微生物目录》内未经有效灭活处理一类病原微生物)
- 3002120099403Other antisera and other blood fractions (clinically collected, containing Class II pathogenic microorganisms from the "Catalog of Pathogenic Microorganisms Transmissible to Humans" that have not been effectively inactivated)其他抗血清及其他血份(临床采集,含《人间传染的病原微生物目录》内未经有效灭活处理二类病原微生物)
- 3002120099404Other antisera and other blood fractions (clinically collected, containing Class 3 pathogenic microorganisms in the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans')其他抗血清及其他血份(临床采集,含《人间传染的病原微生物目录》内三类病原微生物)
- 3002120099405Other antisera and other blood fractions (clinically collected, containing Class 4 pathogenic microorganisms in the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans')其他抗血清及其他血份(临床采集,含《人间传染的病原微生物目录》内四类病原微生物)
- 3002120099406Other antisera and other blood fractions (Fallback tariff item due to splitting of anti-cancer drugs) (Clinically collected, containing pathogenic microorganisms of emerging or re-emerging infectious diseases not on the list)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(临床采集,含新发传染病或名录外再现传染病病原微生物)
- 3002120099407Other antisera and other blood fractions (clinically collected, containing live parasites)其他抗血清及其他血份(临床采集,含活体寄生虫)
- 3002120099408Other antisera and other blood fractions (human antisera and other blood fractions, clinically collected, screened negative for blood-borne pathogens)其他抗血清及其他血份(临床采集,经过血液传播病原体筛查为阴性的人抗血清及其他血份)
- 3002120099409Other antisera & other blood fractions (commercialized products containing Class I pathogenic microorganisms from the "Catalogue of Pathogenic Microorganisms Infectious to Humans" that have not been effectively inactivated)其他抗血清及其他血份(商品化含《人间传染的病原微生物目录》内未经有效灭活处理一类病原微生物)
- 3002120099410Other antisera & other blood fractions (commercialized products containing Class II pathogenic microorganisms from the "Catalogue of Pathogenic Microorganisms Infectious to Humans" that have not been effectively inactivated)其他抗血清及其他血份(商品化含《人间传染的病原微生物目录》内未经有效灭活处理二类病原微生物)
- 3002120099411Other antisera and other blood fractions (commercialized, containing Class III pathogenic microorganisms from the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans')其他抗血清及其他血份(商品化含《人间传染的病原微生物目录》内三类病原微生物)
- 3002120099412Other antisera and other blood fractions (commercialized, containing Class IV pathogenic microorganisms from the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans')其他抗血清及其他血份(商品化含《人间传染的病原微生物目录》内四类病原微生物)
- 3002120099413Other antisera and other blood fractions (commercialized human antisera and other blood fractions screened negative for blood-borne pathogens, excluding those managed as medicines, veterinary medicines, or medical devices)其他抗血清及其他血份(商品化经过血液传播病原体筛查为阴性的人抗血清及其他血份,纳入药品、兽药、医疗器械管理的除外)
- 3002120099414Other antisera and other blood fractions (residual tariff code due to splitting of anticancer drugs) (blood fractions of special blood types for clinical donation matching, excluding those managed as medicines, veterinary drugs, medical devices)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(临床用捐献配型的特殊血型的血份,纳入药品、兽药、医疗器械管理的除外)
- 3002120099415Other antisera and other blood fractions (residual tariff line due to splitting of anti-cancer drugs) (human antisera managed as medicaments)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(按药品管理的人抗血清)
- 3002120099416Other antisera and other blood fractions (residual tariff heading resulting from the breakdown of anti-cancer drugs) (other human antisera, excluding those managed as pharmaceuticals, veterinary drugs, or medical devices)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他人抗血清,纳入药品、兽药、医疗器械管理的除外)
- 3002120099417Other antisera and other blood fractions (residual tariff code due to splitting of anti-cancer drugs) (other human blood fractions, excluding those managed as medicines, veterinary drugs, or medical devices)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(其他人血份,纳入药品、兽药、医疗器械管理的除外)
- 3002120099418Other antisera & other blood fractions (polyclonal antibodies, for human medical related fields, excluding those managed as pharmaceuticals, veterinary drugs, or medical devices)其他抗血清及其他血份(多克隆抗体,用于人类医学相关领域,纳入药品、兽药、医疗器械管理的除外)
- 3002120099419Other antisera and other blood fractions (clinically collected, containing Class 1 pathogenic microorganisms from the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans' effectively inactivated)其他抗血清及其他血份(临床采集,含《人间传染的病原微生物目录》内经有效灭活处理一类病原微生物)
- 3002120099420Other antisera and other blood fractions (clinically collected, containing Class 2 pathogenic microorganisms from the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans' effectively inactivated)其他抗血清及其他血份(临床采集,含《人间传染的病原微生物目录》内经有效灭活处理二类病原微生物)
- 3002120099421Other antisera and other blood fractions (clinically collected, containing non-living parasites)其他抗血清及其他血份(临床采集,含非活体寄生虫)
- 3002120099422Other antisera and other blood fractions (commercialized containing Class I pathogenic microorganisms effectively inactivated as per the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans')其他抗血清及其他血份(商品化含《人间传染的病原微生物目录》内经有效灭活处理一类病原微生物)
- 3002120099423Other antisera and other blood fractions (commercialized containing Class II pathogenic microorganisms effectively inactivated as per the 'Catalogue of Pathogenic Microorganisms Transmissible to Humans')其他抗血清及其他血份(商品化含《人间传染的病原微生物目录》内经有效灭活处理二类病原微生物)
- 3002120099990Other antisera and other blood fractions (catch-all tariff no. due to splitting of anti-cancer drugs) (under pharmaceutical management)其他抗血清及其他血份(因拆分抗癌药产生的兜底税号)(纳入药品管理的)
3002.12.00.11Erythropoietin, such as epoetin alfa, darbepoetin alfa, epoetin beta, epoetin theta, and other erythropoietins唾液酸促红素、氨甲酰促红素、达促红素、培促红素β、促红素类等促红素Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120011101Erythropoietins (medical cytokines) such as sialylated erythropoietin, erythropoietin-derived peptides, carbamylated erythropoietin, darbepoetin, erythropoietin (EPO) class唾液酸促红素、促红素衍生肽、氨甲酰促红素、达促红素、促红素(EPO)类等促红素（医用细胞因子）
- 3002120011401Sialylated erythropoietin, erythropoietin-derived peptides, carbamylated erythropoietin, darbepoetin, peginesatide beta, erythropoietin (EPO) class and other erythropoietins (for human medicine, life science related fields)唾液酸促红素、促红素衍生肽、氨甲酰促红素、达促红素、培促红素β、促红素(EPO)类等促红素(用于人类医学、生命科学相关领域)
- 3002120011999Erythropoietins, such as sialoerythropoietin, erythropoietin-derived peptides, carbamylated erythropoietin, darbepoetin, peginesatide beta, erythropoietin (EPO) class (other chemical products)唾液酸促红素、促红素衍生肽、氨甲酰促红素、达促红素、培促红素β、促红素(EPO)类等促红素(其他化工产品)
3002.12.00.12Insulin-like growth factor 1 (IGF-1) and its analogues胰岛素样生长因子1及其类似物Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120012101Insulin-like growth factor 1 (IGF-1) and its analogues (medicinal cytokines)胰岛素样生长因子1(IGF-1)及其类似物(医用细胞因子)
- 3002120012401Insulin-like growth factor 1 (IGF-1) and its analogues (for human medicine, life sciences related fields)胰岛素样生长因子1(IGF-1)及其类似物(用于人类医学、生命科学相关领域)
- 3002120012999Insulin-like growth factor 1 (IGF-1) and its analogues (other chemical products)胰岛素样生长因子1(IGF-1)及其类似物(其他化工产品)
3002.12.00.13Mechanical growth factors机械生长因子类Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120013101Mechanical growth factor (medicinal cytokines)机械生长因子类(医用细胞因子)
- 3002120013401Mechanical growth factors (for human medicine, life science related fields)机械生长因子类(用于人类医学、生命科学相关领域)
- 3002120013999Mechanical growth factor (other chemical products)机械生长因子类(其他化工产品)
3002.12.00.14Fibroblast growth factors成纤维细胞生长因子类Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120014101Fibroblast growth factors (FGFs) (cytokines for medical use)成纤维细胞生长因子类(FGFs)(医用细胞因子)
- 3002120014401Fibroblast growth factors (FGFs) (for human medicine, life science related fields)成纤维细胞生长因子类(FGFs)(用于人类医学、生命科学相关领域)
- 3002120014999Fibroblast growth factors (FGFs) (other chemical products)成纤维细胞生长因子类(FGFs)(其他化工产品)
3002.12.00.15Hepatocyte growth factor肝细胞生长因子Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120015101Hepatocyte growth factor (HGF) (medical cytokines)肝细胞生长因子(HGF)(医用细胞因子)
- 3002120015401Hepatocyte growth factor (HGF) (for human medicine, life science related fields)肝细胞生长因子(HGF)(用于人类医学、生命科学相关领域)
- 3002120015999Hepatocyte growth factor (HGF) (other chemical products)肝细胞生长因子(HGF)(其他化工产品)
3002.12.00.16Platelet-derived growth factor血小板衍生生长因子Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120016101Platelet-derived growth factor (PDGF) (medicinal cytokine)血小板衍生生长因子(PDGF)(医用细胞因子)
- 3002120016401Platelet-derived growth factor (PDGF) (for human medicine, life sciences)血小板衍生生长因子(PDGF)(用于人类医学、生命科学相关领域)
- 3002120016999Platelet-derived growth factor (PDGF) (other chemical products)血小板衍生生长因子(PDGF)(其他化工产品)
3002.12.00.17Vascular endothelial growth factor血管内皮生长因子Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120017101Vascular endothelial growth factor (VEGF) (medicinal cytokines)血管内皮生长因子(VEGF)(医用细胞因子)
- 3002120017401Vascular endothelial growth factor (VEGF) (for human medicine, life science related fields)血管内皮生长因子(VEGF)(用于人类医学、生命科学相关领域)
- 3002120017999Vascular endothelial growth factor (VEGF) (other chemical products)血管内皮生长因子(VEGF)(其他化工产品)
3002.12.00.18Transforming growth factor-β signal transduction inhibitors转化生长因子-β 信号传导抑制剂类Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120018101Transforming growth factor-β (TGF-β) signal transduction inhibitors (medical cytokines)转化生长因子-β(TGF-β)信号传导抑制剂类(医用细胞因子)
- 3002120018401Transforming growth factor-beta (TGF-β) inhibitors (for human medicine, life sciences related fields)转化生长因子-β(TGF-β)抑制剂类(用于人类医学、生命科学相关领域)
- 3002120018999Transforming growth factor-β (TGF-β) signal transduction inhibitors (other chemical products)转化生长因子-β(TGF-β)信号传导抑制剂类(其他化工产品)
3002.12.00.19Penishapeptide, rotecoxib培尼沙肽、罗特西普Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120019101Penicillopeptide, rotacept (other medicinal proteins)培尼沙肽、罗特西普(其他医用蛋白)
- 3002120019401Penicilide, rotacept (for human medicine, life science related fields)培尼沙肽、罗特西普(用于人类医学、生命科学相关领域)
- 3002120019999Penicillopeptide, rotacept (other chemical products)培尼沙肽、罗特西普(其他化工产品)
3002.12.00.21Hypoxia-inducible factor activators, hypoxia-inducible factor stabilizers缺氧诱导因子激活剂类、缺氧诱导因子稳定剂类Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120021101Hypoxia-inducible factor (HIF) activators, hypoxia-inducible factor (HIF) stabilizers (other medical proteins)缺氧诱导因子(HIF)激活剂类、缺氧诱导因子(HIF)稳定剂类(其他医用蛋白)
- 3002120021401Hypoxia-inducible factor (HIF) activators, hypoxia-inducible factor (HIF) stabilizers (for human medicine, life science related fields)缺氧诱导因子(HIF)激活剂类、缺氧诱导因子(HIF)稳定剂类(用于人类医学、生命科学相关领域)
- 3002120021999Hypoxia-inducible factor (HIF) activators, hypoxia-inducible factor (HIF) stabilizers (other chemical products)缺氧诱导因子(HIF)激活剂类、缺氧诱导因子(HIF)稳定剂类(其他化工产品)
3002.12.00.22EPO-Fc fusion proteinEPO-Fc融合蛋白、EPO-Fc融合蛋白Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120022101EPO-Fc(IgG4) fusion protein, EPO-Fc fusion protein (other medical proteins)EPO-Fc(IgG4)融合蛋白、EPO-Fc融合蛋白(其他医用蛋白)
- 3002120022401EPO-Fc (IgG4) fusion protein, EPO-Fc fusion protein (for human medicine, life science related fields)EPO-Fc(IgG4)融合蛋白、EPO-Fc融合蛋白(用于人类医学、生命科学相关领域)
- 3002120022999EPO-Fc(IgG4) fusion protein, EPO-Fc fusion protein (other chemical products)EPO-Fc(IgG4)融合蛋白、EPO-Fc融合蛋白(其他化工产品)
3002.12.00.24Other goods specified in the "List of Stimulants"其他《兴奋剂目录》所列商品Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 13%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2023
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
- LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether registered with the National Medical Products Administration (NMPA) (please specify)是否经国家药品监督管理部门批准注册请注明
- 5.If approved and registered, declare valid registration certificate number如获得批准注册,请申报有效注册证号
- 6.Whether put up in measured doses是否配定剂量
- 7.Whether in retail packings是否零售包装
- 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
- 9.Model型号
- 10.Packing specifications包装规格
- 11.GTIN
- 12.CAS
- 13.Other其他
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.3%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
RCEP rates
- Australia
- 0%
- Brunei
- 0%
- Cambodia
- 0%
- Laos
- 0%
- Malaysia
- 0%
- New Zealand
- 0%
- Singapore
- 0%
- Thailand
- 0%
- Vietnam
- 0%
- Japan
- 2.7%
CIQ codes
- 3002120024999Other goods specified in the "List of Stimulants"其他《兴奋剂目录》所列商品
3002.12.00.90Other antisera and other blood fractions其他抗血清及其他血份Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 17%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 17%
- Updated by China
- 30 Dec 2018
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
Not listed.
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.4%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
CIQ codes
- 3002120090101Other antisera & other blood fractions (other human blood products)其他抗血清及其他血份(其他人血制品)
- 3002120090999Other antisera & other blood fractions (other chemical products)其他抗血清及其他血份(其他化工产品)
3002.12.00.91Anti-cancer medicaments (excluding adjuvant therapy medicaments for cancer)抗(防)癌药品制剂(不含癌症辅助治疗药品)Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 3%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2021
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether or not for calibration reference是否为检定参照物
- 7.Brand品牌
- 8.Model型号
- 9.Packing specifications包装规格
- 10.GTIN
- 11.CAS
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.4%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
CIQ codes
- 3002120091301Anti-cancer medicaments (excluding adjuvant therapy for cancer) (other chemical products)抗(防)癌药品制剂(不含癌症辅助治疗药品)(其他化工产品)
- 3002120091401Anti-cancer medicaments (excluding adjuvant therapy for cancer) (other human blood products)抗(防)癌药品制剂(不含癌症辅助治疗药品)(其他人血制品)
3002.12.00.92Human coagulation factor VIII, recombinant human coagulation factor VIII for injection, recombinant human coagulation factor IX for injection, recombinant human coagulation factor VIIa for injection, human prothrombin complex人凝血因子Ⅷ、注射用重组人凝血因子Ⅷ、注射用重组人凝血因子Ⅸ、注射用重组人凝血因子Ⅶa、人凝血酶原复合物Expired
- Unit
- kg
- MFN import duty
- 3%
- Provisional import duty
- 0%
- General import duty
- 20%
- Import VAT
- 3%
- Consumption tax
- None
- Export duty
- 0%
- Provisional export duty
- None
- Export VAT rebate
- 13%
- Updated by China
- 4 Jan 2021
Licences and certificates
- AInbound goods clearance (inspection and quarantine)入境货物通关单
- BOutbound goods clearance (inspection and quarantine)出境货物通关单
Inspection and quarantine
- PInbound animal and plant (product) quarantine进境动植物、动植物产品检疫
- QOutbound animal and plant (product) quarantine出境动植物、动植物产品检疫
- VInbound health quarantine代表入境卫生检疫
- WOutbound health quarantine代表出境卫生检疫
What the customs declaration must state
- 0.Brand type品牌类型
- 1.Export preferential status出口享惠情况
- 2.Use用途
- 3.Processing method加工工艺
- 4.Whether put up in measured doses是否配定剂量
- 5.Whether in retail packings是否零售包装
- 6.Whether or not for calibration reference是否为检定参照物
- 7.Brand品牌
- 8.Model型号
- 9.Packing specifications包装规格
- 10.GTIN
- 11.CAS
China's agreement rates
- ASEAN
- 0%
- Chile
- 0%
- Pakistan
- 0%
- New Zealand
- 0%
- Peru
- 0%
- Costa Rica
- 0%
- Switzerland
- 1.4%
- Iceland
- 0%
- Australia
- 0%
- South Korea
- 0%
- Georgia
- 0%
- Mauritius
- 0%
China's tariff as compiled by HS编码网 from China Customs, the State Council Tariff Commission and the State Taxation Administration. The Chinese is the original.
Nearby codes
Sources
- GSTN HSN code masterChecked 13 Oct 2026
- DGFT ITC(HS) import and export policyChecked 9 Oct 2026
- GST rate per HSN (archived GSTZen extract)Checked 29 Sep 2026
- Customs Tariff of India (First Schedule): sections, chapters, notes and statutory BCDChecked 19 Oct 2026
- GST rates on goods, before and after 22 September 2025Checked 18 Oct 2026
- BIS compulsory certification: products and Quality Control OrdersChecked 18 Oct 2026
- Anti-dumping, countervailing and safeguard duties in force (India)Checked 19 Oct 2026
- India import tariff by origin (Indian Trade Portal snapshot)Checked 29 Sep 2026
- GST schedule headings and 8-digit IGST (archived)Checked 29 Sep 2026
- HS code descriptions (archived file)Checked 29 Sep 2026
- India's effective basic customs duty (notification 45/2025-Customs, Table I)Checked 19 Oct 2026
- India's AIDC, Health Cess and Social Welfare Surcharge exemptions (11/2021, 08/2020, 11/2018-Customs)Checked 18 Oct 2026
- India's preferential tariff schedules (CBIC notifications)Checked 19 Oct 2026
- India's export duty (Second Schedule to the Customs Tariff Act and notifications 27/2011, 55/2022, 22/2024)Checked 18 Oct 2026
- India's All Industry Rates of duty drawback (notification 77/2023-Customs (N.T.))Checked 19 Oct 2026
- RoDTEP export incentive rates (DGFT Appendix 4R and 4RE)Checked 18 Oct 2026
- RoSCTL rebate for apparel and made-ups (Ministry of Textiles): periods and ratesChecked 19 Oct 2026
- CBIC Compliance Information Portal (CIP)Checked 19 Oct 2026
- China customs tariff (HS编码网)Checked 19 Oct 2026
For information, not a customs ruling. Only notifications published in the Gazette have legal force; confirm the duty with your customs broker or ICEGATE before you price a deal.